Major financial milestone via Series D1 funding On January 23, 2026, Corxel Pharmaceuticals announced the closure of a $287 million... Read more
Tag: #Global Trends
United States officially concludes withdrawal from WHO
Termination of relations and resource withdrawal On January 23, the U.S. Department of Health and Human Services (HHS) announced the... Read more
FDA Outlines Draft Policy on Using MRD to Expedite Multiple Myeloma Drug Approvals
The U.S. Food and Drug Administration (FDA) has issued a draft guidance for the industry, proposing the use of Minimal... Read more
EU Approves Otsuka’s Dawnzera as First RNA-Targeted Therapy for HAE
The European Commission (EC) has granted marketing authorization for Otsuka’s Dawnzera (donidalorsen) for the routine prevention of recurrent attacks in... Read more
China’s Clinical Trial Reforms Create Strategic Opportunities for Global Biopharma
China has transitioned from having one of the world's most sluggish drug approval systems to one of the fastest. This... Read more
BD and Ypsomed Strengthen Partnership with New 5.5mL Syringe Variant
Medical technology leaders BD (Becton, Dickinson and Company) and Ypsomed have expanded their ongoing collaboration by introducing a new 5.5mL... Read more
Datwyler Introduces Industry’s First Large-Volume Universal Plunger
Responding to the rise of at-home patient care, Datwyler has launched a first-to-market universal plunger designed for large-volume cartridges of... Read more
Novo Nordisk and Aspect Biosystems Advance Strategic Diabetes Partnership
Novo Nordisk and Aspect Biosystems have entered a new phase of their collaboration aimed at developing curative cell-based medicines for... Read more
CDC Official Downplays Potential Loss of U.S. Measles Elimination Status
Amid expanding measles outbreaks across several states, a top official at the Centers for Disease Control and Prevention (CDC) suggested... Read more









